NVRO RSI Chart
Last 7 days
2.0%
Last 30 days
-8.3%
Last 90 days
-30.7%
Trailing 12 Months
-61.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 414.9M | 419.4M | 422.8M | 425.2M |
2022 | 386.1M | 388.0M | 395.3M | 406.4M |
2021 | 363.2M | 409.1M | 393.9M | 386.9M |
2020 | 395.6M | 358.4M | 366.7M | 362.0M |
2019 | 381.8M | 379.3M | 383.8M | 390.3M |
2018 | 345.9M | 363.9M | 377.3M | 387.3M |
2017 | 255.3M | 277.9M | 299.2M | 326.7M |
2016 | 101.6M | 145.6M | 191.1M | 228.5M |
2015 | 35.6M | 39.5M | 46.2M | 69.6M |
2014 | 24.8M | 26.6M | 29.1M | 32.6M |
2013 | 19.5M | 20.8M | 22.2M | 23.5M |
2012 | 0 | 0 | 0 | 18.1M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 11, 2024 | grossman d keith | sold (taxes) | -52,296 | 13.12 | -3,986 | - |
Apr 04, 2024 | rashid kashif | sold (taxes) | -6,327 | 13.21 | -479 | svp, corp dev and clo |
Mar 31, 2024 | weatherman elizabeth h | acquired | - | - | 1,372 | - |
Mar 31, 2024 | fischer frank m | acquired | - | - | 1,159 | - |
Mar 31, 2024 | demane michael f | acquired | - | - | 1,817 | - |
Mar 31, 2024 | kosaraju sridhar | acquired | - | - | 1,090 | - |
Mar 11, 2024 | grossman d keith | sold (taxes) | -32,738 | 14.99 | -2,184 | - |
Mar 07, 2024 | carter richard b. | sold (taxes) | -41,455 | 15.32 | -2,706 | chief accounting officer |
Mar 07, 2024 | macleod roderick h. | acquired | - | - | 84,326 | chief financial officer |
Mar 07, 2024 | macleod roderick h. | sold (taxes) | -109,324 | 15.32 | -7,136 | chief financial officer |
Which funds bought or sold NVRO recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 23, 2024 | AMALGAMATED BANK | reduced | -66.81 | -64,000 | 18,000 | -% |
Apr 22, 2024 | MetLife Investment Management, LLC | unchanged | - | 43,562 | 407,589 | -% |
Apr 18, 2024 | McGlone Suttner Wealth Management, Inc. | sold off | -100 | -6,456 | - | -% |
Apr 05, 2024 | CWM, LLC | added | 6.11 | -4,000 | 11,000 | -% |
Apr 05, 2024 | GAMMA Investing LLC | new | - | 895 | 895 | -% |
Apr 03, 2024 | Versant Capital Management, Inc | sold off | -100 | -882 | - | -% |
Mar 27, 2024 | NOMURA HOLDINGS INC | added | 28.11 | 386,135 | 1,275,060 | -% |
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | added | 18.52 | 1,187 | 4,820 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | reduced | -3.89 | 6,190,460 | 87,527,700 | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 239 | 33,250,400 | 45,107,100 | -% |
Unveiling Nevro Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Nevro Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 185.5B | 40.1B | 32.41 | 4.63 | ||||
BDX | 67.5B | 19.5B | 53.77 | 3.46 | ||||
ALGN | 23.6B | 3.9B | 52.95 | 6.1 | ||||
BAX | 20.8B | 14.8B | 7.83 | 1.4 | ||||
MID-CAP | ||||||||
HSIC | 9.4B | 12.3B | 22.62 | 0.76 | ||||
ATR | 9.2B | 3.5B | 32.49 | 2.65 | ||||
BIO | 8.1B | 2.7B | -12.74 | 3.04 | ||||
XRAY | 6.4B | 4.0B | -47.67 | 1.62 | ||||
AXNX | 3.4B | 366.4M | -560.04 | 9.28 | ||||
PDCO | 2.3B | 6.6B | 12.12 | 0.36 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.92 | 0.41 | ||||
ANIK | 384.6M | 166.7M | -4.65 | 2.31 | ||||
ANGO | 235.1M | 324.0M | -1.22 | 0.73 | ||||
APYX | 52.0M | 52.3M | -2.78 | 0.99 | ||||
AEMD | 4.0M | 3.7M | -0.33 | 1.07 |
Nevro Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 11.9% | 116,176,000 | 103,862,000 | 108,809,000 | 96,327,000 | 113,844,000 | 100,466,000 | 104,213,000 | 87,842,000 | 102,760,000 | 93,205,000 | 102,330,000 | 88,610,000 | 109,731,000 | 108,460,000 | 56,390,000 | 87,467,000 | 114,374,000 | 100,162,000 | 93,571,000 | 82,148,000 | 107,944,000 |
Gross Profit | 17.2% | 81,477,000 | 69,516,000 | 74,443,000 | 64,624,000 | 75,239,000 | 69,302,000 | 72,734,000 | 59,092,000 | 69,132,000 | 64,630,000 | 69,986,000 | 62,294,000 | 78,028,000 | 76,077,000 | 35,250,000 | 60,547,000 | 81,258,000 | 69,940,000 | 63,943,000 | 53,209,000 | 76,154,000 |
Operating Expenses | -100.0% | - | 95,075,000 | 100,082,000 | 100,947,000 | 94,597,000 | -12,780,000 | 96,525,000 | 91,861,000 | 95,347,000 | 111,074,000 | 85,749,000 | 84,806,000 | 78,903,000 | 79,626,000 | 70,611,000 | 83,614,000 | 92,939,000 | 85,924,000 | 90,503,000 | 95,463,000 | 84,757,000 |
S&GA Expenses | -0.7% | 80,598,000 | 81,152,000 | 86,762,000 | 86,192,000 | 80,650,000 | 78,190,000 | 83,973,000 | 79,325,000 | 82,638,000 | 79,521,000 | 73,880,000 | 73,272,000 | 67,073,000 | 68,512,000 | 60,167,000 | 71,402,000 | 76,006,000 | 72,905,000 | 75,573,000 | 81,328,000 | 71,277,000 |
R&D Expenses | -10.8% | 12,420,000 | 13,923,000 | 13,320,000 | 14,755,000 | 13,947,000 | 14,030,000 | 12,552,000 | 12,536,000 | 12,709,000 | 11,553,000 | 11,869,000 | 11,534,000 | 11,830,000 | 11,114,000 | 10,444,000 | 12,212,000 | 16,933,000 | 13,019,000 | 14,930,000 | 14,135,000 | 13,480,000 |
EBITDA Margin | 6.4% | -0.20 | -0.21 | 0.04 | 0.04 | 0.04 | 0.02 | -0.32 | -0.30 | -0.27 | -0.20 | -0.09 | -0.16 | - | - | - | - | - | - | - | - | - |
Interest Expenses | 95.6% | 3,165,000 | 1,618,000 | 1,618,000 | 1,613,000 | 1,613,000 | 1,608,000 | 1,608,000 | 1,603,000 | 3,810,000 | 3,688,000 | 5,704,000 | 6,547,000 | 6,495,000 | 6,363,000 | 6,122,000 | 2,826,000 | 2,778,000 | 2,755,000 | 2,710,000 | 2,688,000 | 2,642,000 |
Income Taxes | -5160.0% | -6,578,000 | 130,000 | 477,000 | 325,000 | 356,000 | 485,000 | 241,000 | 181,000 | -78,000 | 72,000 | 198,000 | 342,000 | 310,000 | 208,000 | 44,000 | 306,000 | 481,000 | 420,000 | 358,000 | 340,000 | -509,000 |
Earnings Before Taxes | 33.4% | -15,559,000 | -23,349,000 | -24,247,000 | -34,704,000 | -18,836,000 | 81,993,000 | -24,749,000 | -34,144,000 | -30,212,000 | -50,003,000 | -21,392,000 | -29,219,000 | -6,819,000 | -9,777,000 | -41,019,000 | -24,582,000 | -13,261,000 | -17,427,000 | -27,663,000 | -43,736,000 | -10,116,000 |
EBT Margin | 3.8% | -0.23 | -0.24 | 0.01 | 0.01 | 0.01 | -0.02 | -0.36 | -0.35 | -0.34 | -0.27 | -0.16 | -0.24 | - | - | - | - | - | - | - | - | - |
Net Income | 61.7% | -8,981,000 | -23,479,000 | -24,724,000 | -35,029,000 | -19,192,000 | 81,508,000 | -24,990,000 | -34,325,000 | -30,134,000 | -50,075,000 | -21,590,000 | -29,561,000 | -7,129,000 | -9,985,000 | -41,063,000 | -24,888,000 | -13,742,000 | -17,847,000 | -28,021,000 | -44,076,000 | -9,607,000 |
Net Income Margin | 10.5% | -0.22 | -0.24 | 0.01 | 0.01 | 0.01 | -0.02 | -0.36 | -0.35 | -0.34 | -0.28 | -0.17 | -0.24 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -34.4% | -10,785,000 | -8,026,000 | -16,710,000 | -31,902,000 | -15,810,000 | 77,237,000 | -14,269,000 | -30,025,000 | -16,889,000 | -19,037,000 | -8,869,000 | -9,426,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 13.2% | 636 | 562 | 570 | 574 | 602 | 606 | 524 | 533 | 575 | 582 | 600 | 776 | 789 | 778 | 753 | 460 | 470 | 448 | 448 | 458 | 463 |
Current Assets | 1.7% | 531 | 522 | 531 | 535 | 563 | 566 | 483 | 490 | 531 | 539 | 557 | 739 | 753 | 742 | 717 | 414 | 422 | 401 | 401 | 410 | 444 |
Cash Equivalents | 60.0% | 104 | 65.00 | 65.00 | 64.00 | 120 | 131 | 109 | 49.00 | 35.00 | 81.00 | 146 | 87.00 | 45.00 | 119 | 277 | 136 | 65.00 | 49.00 | 63.00 | 41.00 | 51.00 |
Inventory | -3.1% | 119 | 122 | 120 | 113 | 100 | 99.00 | 94.00 | 91.00 | 94.00 | 92.00 | 86.00 | 86.00 | 83.00 | 84.00 | 92.00 | 93.00 | 92.00 | 91.00 | 92.00 | 93.00 | 92.00 |
Net PPE | 2.2% | 25.00 | 24.00 | 24.00 | 23.00 | 22.00 | 21.00 | 21.00 | 21.00 | 21.00 | 20.00 | 19.00 | 15.00 | 14.00 | 12.00 | 11.00 | 11.00 | 12.00 | 12.00 | 12.00 | 12.00 | 13.00 |
Liabilities | 24.2% | 343 | 276 | 275 | 273 | 279 | 281 | 294 | 292 | 271 | 263 | 241 | 409 | 401 | 399 | 379 | 245 | 253 | 250 | 246 | 244 | 218 |
Current Liabilities | 4.6% | 83.00 | 80.00 | 78.00 | 75.00 | 79.00 | 80.00 | 73.00 | 70.00 | 82.00 | 75.00 | 74.00 | 246 | 239 | 239 | 221 | 61.00 | 71.00 | 68.00 | 66.00 | 65.00 | 62.00 |
Short Term Borrowings | - | - | - | - | - | - | - | - | - | - | - | - | 171 | 169 | 167 | 164 | - | - | - | - | - | - |
Long Term Debt | 12.6% | 211 | 188 | 187 | 187 | 187 | 187 | 186 | 186 | 34.00 | 149 | 146 | 144 | 142 | 140 | 137 | 162 | 160 | 158 | 156 | 154 | 152 |
LT Debt, Non Current | 12.6% | 211 | 188 | 187 | 187 | 187 | 187 | 186 | 186 | 34.00 | 149 | 146 | 144 | 142 | 140 | 137 | 162 | 160 | 158 | 156 | 154 | 152 |
Shareholder's Equity | 2.6% | 293 | 286 | 295 | 301 | 324 | 325 | 230 | 240 | 304 | 319 | 358 | 366 | 388 | 380 | 374 | 215 | 216 | 198 | 202 | 214 | 245 |
Retained Earnings | -1.3% | -699 | -690 | -666 | -642 | -607 | -588 | -669 | -644 | -624 | -594 | -543 | -522 | -492 | -485 | -475 | -434 | -409 | -396 | -378 | -350 | -306 |
Additional Paid-In Capital | 1.5% | 993 | 978 | 964 | 945 | 934 | 918 | 903 | 886 | 928 | 913 | 902 | 888 | 881 | 865 | 851 | 651 | 626 | 595 | 580 | 565 | 553 |
Shares Outstanding | 0.5% | 36.00 | 36.00 | 36.00 | 36.00 | 36.00 | 35.00 | 35.00 | 35.00 | 35.00 | 35.00 | 35.00 | 35.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | 896 | - | - | - | 1,521 | - | - | - | 5,695 | - | - | - | 4,009 | - | - | - | 1,923 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -46.5% | -8,923 | -6,090 | -14,502 | -29,314 | -13,423 | 79,350 | -12,834 | -28,418 | -15,159 | -15,362 | -4,489 | -6,871 | 11,859 | 11,336 | -16,823 | -5,181 | -13,475 | -3,373 | -11,670 | -21,707 | 5,000 |
Share Based Compensation | 0.7% | 13,617 | 13,523 | 16,166 | 13,560 | 14,807 | 15,206 | 13,377 | 13,408 | 11,459 | 12,637 | 11,034 | 9,237 | 10,118 | 13,965 | 10,083 | 8,489 | 10,382 | 11,192 | 9,721 | 10,402 | 9,619 |
Cashflow From Investing | -115.3% | -1,113 | 7,283 | 11,274 | -24,648 | 458 | -56,504 | 70,269 | 50,067 | -34,232 | -48,185 | 233,790 | 50,342 | -92,111 | -170,131 | -167,920 | 60,294 | 7,646 | -12,538 | 27,881 | 9,341 | 23,702 |
Cashflow From Financing | 4907.3% | 48,698 | -1,013 | 4,122 | -2,273 | 1,374 | 37.00 | 2,885 | -6,753 | 3,276 | -1,325 | -169,862 | -1,470 | 5,139 | 761 | 324,827 | 16,178 | 21,389 | 3,009 | 5,921 | 1,774 | 1,299 |
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement [Abstract] | |||
Revenue | $ 425,174 | $ 406,365 | $ 386,905 |
Cost of revenue | 135,114 | 129,998 | 120,863 |
Gross profit | 290,060 | 276,367 | 266,042 |
Operating expenses | |||
Research and development | 54,418 | 53,065 | 47,665 |
Sales, general and administrative | 334,704 | 322,138 | 309,311 |
Amortization of intangibles | 246 | ||
Certain litigation charges | (105,000) | 20,000 | |
Total operating expenses | 389,368 | 270,203 | 376,976 |
Income (loss) from operations | (99,308) | 6,164 | (110,934) |
Interest income | 14,166 | 4,021 | 671 |
Interest expense | (8,014) | (6,432) | (19,749) |
Change in fair market value of warrants | (8,051) | ||
Other income (expense), net | (586) | 511 | (814) |
Gain on extinguishment of debt | 3,934 | ||
Income (loss) before income taxes | (97,859) | 4,264 | (130,826) |
Provision for income taxes | (5,646) | 1,263 | 534 |
Net income (loss) | (92,213) | 3,001 | (131,360) |
Other comprehensive income (loss): | |||
Changes in foreign currency translation adjustment | 1,164 | (1,667) | (469) |
Changes in unrealized gains (losses) on short-term investments, net | 1,687 | (1,063) | (493) |
Net change in other comprehensive income (loss) | 2,851 | (2,730) | (962) |
Comprehensive income (loss) | $ (89,362) | $ 271 | $ (132,322) |
Net income (loss) per share | |||
Basic | $ (2.56) | $ 0.08 | $ (3.77) |
Diluted | $ (2.56) | $ 0.08 | $ (3.77) |
Weighted average number of common shares used to net income (loss) per share | |||
Basic | 35,981,431 | 35,317,644 | 34,823,258 |
Diluted | 35,981,431 | 35,525,255 | 34,823,258 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 104,217 | $ 120,373 |
Short-term investments | 218,506 | 254,012 |
Accounts receivable, net of allowance for doubtful accounts of $1,048 and $1,270 at December 31, 2023 and 2022, respectively | 79,377 | 78,930 |
Inventories | 118,676 | 99,638 |
Prepaid expenses and other current assets | 10,145 | 9,984 |
Total current assets | 530,921 | 562,937 |
Property and equipment, net | 24,568 | 22,271 |
Operating lease assets | 8,944 | 13,430 |
Goodwill | 38,164 | |
Intangible assets, net | 27,354 | |
Other assets | 5,156 | 3,164 |
Restricted cash | 606 | 606 |
Total assets | 635,713 | 602,408 |
Current liabilities | ||
Accounts payable | 22,520 | 26,849 |
Accrued liabilities | 45,297 | 47,168 |
Contingent liabilities, current portion | 9,836 | |
Other current liabilities | 5,722 | 5,195 |
Total current liabilities | 83,375 | 79,212 |
Long-term debt | 211,471 | 186,867 |
Long-term operating lease liabilities | 4,634 | 10,296 |
Contingent liabilities, non-current portion | 12,257 | |
Warrant liability | 28,739 | |
Other long-term liabilities | 2,092 | 2,157 |
Total liabilities | 342,568 | 278,532 |
Commitments and contingencies (Note 7) | ||
Stockholders’ equity | ||
Preferred stock, $0.001 par value, 10,000,000 shares authorized at December 31, 2023 and 2022, respectively; zero shares issued and outstanding at December 31, 2023 and 2022, respectively | ||
Common stock, $0.001 par value, 290,000,000 shares authorized at December 31, 2023 and 2022, respectively; 37,044,390 and 36,203,423 shares issued at December 31, 2023 and 2022, respectively; 36,361,474 and 35,520,507 shares outstanding at December 31, 2023 and 2022, respectively | 36 | 35 |
Additional paid-in capital | 992,762 | 934,132 |
Accumulated other comprehensive income / (loss) | (243) | (3,094) |
Accumulated deficit | (699,410) | (607,197) |
Total stockholders’ equity | 293,145 | 323,876 |
Total liabilities and stockholders’ equity | $ 635,713 | $ 602,408 |